Form 4 for EW Edwards Lifesciences
Accepted 2025-06-03 00:00:00 ET · period of report 2025-05-30 · accession 0001225208-25-005684 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| MI | 2025-06-03 | 2025-05-30+ | EW | Zovighian Bernard J | CEO, Dir | S - Sale | $77.22 | -17.1K | 9,564 | -64% | -$1.32M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-06-03 | S | D | 967 | $77.32 | 8,596.55 | I By Trust | — | — | (F3) This transaction was executed in multiple trades at prices ranging from $77.140 to $77.540 The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected. |
| 2 | Common | Common Stock | 2025-05-30 | S | D | 16,099 | $77.21 | 9,563.55 | I By Trust | — | — | (F2) This transaction was executed in multiple trades at prices ranging from $76.930 to $77.585 The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected. |